The U.S. Food and Drug Administration (FDA) has approved celecoxib capsules — a generic form of Pfizer’s Celebrex — to treat inflammation and pain in juvenile idiopathic arthritis (JIA) and other chronic conditions. India-based Unichem Laboratories was granted approval of its abbreviated new drug application (ANDA) for four doses of the celecoxib generic, the company announced in a press release. With the FDA approval, the generic, given in capsules, will now be available at 50 mg,…

You must be logged in to read/download the full post.